Lisa M. DiGianni, Ph.D.

Dana-Farber Cancer Institute

Dana-Farber Cancer Institute
Phone: (617) 632-5429
Fax: (617) 632-3161


lisa_digianni@dfci.harvard.edu

Lisa M. DiGianni, Ph.D.

Dana-Farber Cancer Institute

EDUCATIONAL TITLES

  • Senior Research Scientist, Population Sciences, Dana-Farber Cancer Institute

DF/HCC PROGRAM AFFILIATION

Publications

Powered by Harvard Catalyst
  • Keating NL,Stoeckert KA,Regan MM,DiGianni L,Garber JE. Physicians' experiences with BRCA1/2 testing in community settings. J Clin Oncol 2008; 26:5789-96. PubMed
  • Masciari S, Van den Abbeele AD, Diller LR, Rastarhuyeva I, Yap J, Schneider K, Digianni L, Li FP, Fraumeni JF Jr, Syngal S, Garber JE. F18-fluorodeoxyglucose-positron emission tomography/computed tomography screening in Li-Fraumeni syndrome. JAMA 2008; 299:1315-9. PubMed
  • Patenaude AF, Dorval M, DiGianni LS, Schneider KA, Chittenden A, Garber JE. Sharing BRCA1/2 test results with first-degree relatives: factors predicting who women tell. J Clin Oncol 2006; 24:700-6. PubMed
  • Digianni LM, Rue M, Emmons K, Garber JE. Complementary medicine use before and 1 year following genetic testing for BRCA1/2 mutations. Cancer Epidemiol Biomarkers Prev 2006; 15:70-5. PubMed
  • Wong P, Verselis SJ, Garber JE, Schneider K, DiGianni L, Stockwell DH, Li FP, Syngal S. Prevalence of early onset colorectal cancer in 397 patients with classic Li-Fraumeni syndrome. Gastroenterology 2006; 130:73-9. PubMed
  • Schneider KA, DiGianni LM, Patenaude AF, Klar N, Stopfer JE, Calzone KA, Li FP, Weber BL, Garber JE. Accuracy of cancer family histories: comparison of two breast cancer syndromes. Genet Test 2005; 8:222-8. PubMed
  • DiGianni LM, Kim HT, Emmons K, Gelman R, Kalkbrenner KJ, Garber JE. Complementary medicine use among women enrolled in a genetic testing program. Cancer Epidemiol Biomarkers Prev 2003; 12:321-6. PubMed
  • Li FP, DiGianni LM. Reducing the unequal burden of cancer. Cancer Epidemiol Biomarkers Prev 2003; 12:230s-231s. PubMed
  • DiGianni LM, Garber JE, Winer EP. Complementary and alternative medicine use among women with breast cancer. J Clin Oncol 2002; 20:34S-8S. PubMed
  • Dorval M, Patenaude AF, Schneider KA, Kieffer SA, DiGianni L, Kalkbrenner KJ, Bromberg JI, Basili LA, Calzone K, Stopfer J, Weber BL, Garber JE. Anticipated versus actual emotional reactions to disclosure of results of genetic tests for cancer susceptibility: findings from p53 and BRCA1 testing programs. J Clin Oncol 2000; 18:2135-42. PubMed
  • Emmons KM, Sorensen G, Klar N, Digianni L, Barclay G, Schmidt K, Hammond SK. Healthy baby second-hand smoke study: project brief. Tob Control 2000; 9 Suppl 3:III58-60. PubMed